Article
[Autologous peripheral blood stem cell transplantation for double-refractory myeloma with K-RAS and N-RAS mutations].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2000
Jimbo Koji, Yokoyama Kazuaki, Ogawa Miho, Hirano Mitsuhito, Ochi Kiyosumi, Kobayashi Masayuki, Yusa Nozomi, Shimizu Eigo, Kawamata Toyotaka, Yasui Hiroshi, Ohno Nobuhiro, Yamaguchi Rui, Imoto Seiya, Furukawa Yoichi, Miyano Satoru, Imai Yoichi, Tojo Arinobu
Abstract excerpt
The prognosis of multiple myeloma (MM) has been improved due to the introduction of novel agents like proteasome inhibitors and immunomodulatory drugs (IMiDs). However, some cases are refractory to the use of novel agents, and the prognosis of such cases is poor. A 53-year-old male was diagnosed with MM and categorized as follows: Bence-Jones protein lambda type MM, Durie-Salmon IIIA, international staging system...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.